Cargando…
Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support—Results of a Prospective, Randomized, Comparative Study
Background. The aim of this pilot study was to evaluate intranasal buserelin for luteal phase support and compare its efficacy with standard vaginal progesterone in IVF/ICSI antagonist cycles. Methods. This is a prospective, randomized, open, parallel group study. Forty patients underwent ovarian hy...
Autores principales: | Pirard, Céline, Loumaye, Ernest, Laurent, Pascale, Wyns, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402188/ https://www.ncbi.nlm.nih.gov/pubmed/25945092 http://dx.doi.org/10.1155/2015/727569 |
Ejemplares similares
-
Comparison of GnRH agonist versus luteal estradiol
GnRH antagonist protocol using transdermal testosterone in poor
responders
por: Fàbregues, Francesc, et al.
Publicado: (2019) -
Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial
por: Benmachiche, Abdelhamid, et al.
Publicado: (2017) -
Luteal blood flow in patients undergoing GnRH agonist long protocol
por: Takasaki, Akihisa, et al.
Publicado: (2011) -
Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial
por: Salehpour, Saghar, et al.
Publicado: (2021) -
Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)